Abiopharma

🔍 Barrett John Frederick (Executive)

Company: NN INC (NNBR)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 315,436 shares of Common Stock, par value $0.01 per share at $2.0563 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,890,195.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 40,030 shares of Common Stock, par value $0.01 per share at $2.0411 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,850,165.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 348,161 shares of Common Stock, par value $0.01 per share at $2.2939 per share (Direct)
  Date: 2026-04-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,502,004.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 79,757 shares of Common Stock, par value $0.01 per share at $2.2423 per share (Direct)
  Date: 2026-04-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,422,247.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 55,483 shares of Common Stock, par value $0.01 per share at $2.2096 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,366,764.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 94,380 shares of Common Stock, par value $0.01 per share at $2.2978 per share (Direct)
  Date: 2026-04-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,272,384.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 555,305 shares of Common Stock, par value $0.01 per share at $2.6904 per share (Direct)
  Date: 2026-04-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,717,079.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 12,199 shares of Common Stock, par value $0.01 per share at $2.5138 per share (Direct)
  Date: 2026-04-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,704,880.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 136,165 shares of Common Stock, par value $0.01 per share at $2.6295 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,568,715.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2

Footnotes:

• F1: All trades in this Form 4 were previously reported on Form 4 filings made by Corre Partners Management, LLC ("Corre") on April 17, 2026, April 22, 2026 and April 27, 2026. The Reporting Person is filing this Form 4 as a result of the Reporting Person subsequently receiving CIK codes.
• F2: The reported securities are directly owned by advisory clients of Corre. The reported securities may be deemed beneficially owned by the Reporting Person, the managing member of Corre. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.00 to $2.17. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.015 to $2.105. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.04 to $2.445. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.20 to $2.3066. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.17 to $2.29. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.2050 to $2.38. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.49 to $2.88. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.50 to $2.54. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $2.52 to $2.7099. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.